| Digoxin Pediatric Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Digoxin Pediatric 100 mcg/mL (0.1 mg/mL) | solution | injectable | 1.0 milliliter(s) | OTC |
The Importance of Randomized Controlled Trials in Pediatric Cardiology - Journal of American Medical Association (subscription)
Experience with randomized controlled clinical trials in pediatric cardiology is limited. Perhaps the most cited article in the field had a sample size of 1 ...
Tue Sep 11 12:53:27 -0400 2007
New Studies Evaluating NEXIUM(R) In Pediatric GERD To Be Presented ... - Earthtimes.org
WASHINGTON, May 22 -- AstraZeneca will present several studies today regarding pediatric patients with gastroesophageal reflux disease (GERD) during oral ...
Tue May 22 05:25:53 -0400 2007
digoxin - A cardiac glycoside. Digoxin inhibits the sodium potassium adenosine triphosphatase (ATPase) pump, thereby increasing intracellular calcium and enhancing cardiac contractility. This agent also acts directly on the atrioventricular node to suppress conduction, thereby slowing conduction velocity. Apparently due to its effects on intracellular calcium concentrations, digoxin induces apoptosis of tumor cells via a pathway involving mitochondrial cytochrome c and caspases 8 and 3. (NCI04)